20:11

Advancing Medicines for Charcot-Marie-Tooth Disease

24:03

AAV Vector Delivery Strategies for Peripheral Nerves

22:01

Targeting SARM1 and Axon Degeneration as a Design-Modifying Strategy for the Treatment of CMT2A

53:57

Keynote: From Genes to Treatments: Strategic Considerations for CMT Therapy Development

33:55

Funding CMT Research–Insight Into the Current Funding Environment and Ways to Overcome Challenges